These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17548652)

  • 1. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
    Sheibanie AF; Yen JH; Khayrullina T; Emig F; Zhang M; Tuma R; Ganea D
    J Immunol; 2007 Jun; 178(12):8138-47. PubMed ID: 17548652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
    Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
    Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.
    Khayrullina T; Yen JH; Jing H; Ganea D
    J Immunol; 2008 Jul; 181(1):721-35. PubMed ID: 18566439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis.
    Zhou J; Lai W; Yang W; Pan J; Shen H; Cai Y; Yang C; Ma N; Zhang Y; Zhang R; Xie X; Dong Z; Gao Y; Du C
    Cell Mol Immunol; 2018 Dec; 15(12):1047-1056. PubMed ID: 29670278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
    Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
    Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.
    Sheibanie AF; Tadmori I; Jing H; Vassiliou E; Ganea D
    FASEB J; 2004 Aug; 18(11):1318-20. PubMed ID: 15180965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.
    Alves VBF; de Sousa BC; Fonseca MTC; Ogata H; Caliári-Oliveira C; Yaochite JNU; Rodrigues Júnior V; Chica JEL; da Silva JS; Malmegrim KCR; Pernomian L; Cardoso CR
    Clin Exp Immunol; 2019 May; 196(2):139-154. PubMed ID: 30663040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
    Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
    Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.
    Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M
    Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
    Feng T; Qin H; Wang L; Benveniste EN; Elson CO; Cong Y
    J Immunol; 2011 Jun; 186(11):6313-8. PubMed ID: 21531892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
    Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
    J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis.
    Yin H; Li X; Zhang B; Liu T; Yuan B; Ni Q; Hu S; Gu H
    Immunology; 2013 Aug; 139(4):494-502. PubMed ID: 23480027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.
    Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.
    Kabashima K; Saji T; Murata T; Nagamachi M; Matsuoka T; Segi E; Tsuboi K; Sugimoto Y; Kobayashi T; Miyachi Y; Ichikawa A; Narumiya S
    J Clin Invest; 2002 Apr; 109(7):883-93. PubMed ID: 11927615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
    Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
    Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.